Younger gout patients have higher odds for blood clots
Older age raises the odds of many ills, but for adults with gout, it's the younger ones who have the highest risk for developing a serious blood clot, new research indicates.
Jun 3, 2019
0
1
Older age raises the odds of many ills, but for adults with gout, it's the younger ones who have the highest risk for developing a serious blood clot, new research indicates.
Jun 3, 2019
0
1
LDL cholesterol – the so-called "bad" cholesterol – is known to narrow arteries, which can lead to heart attacks and strokes. It's also now suspected of contributing to venous thromboembolism, new research suggests.
May 14, 2019
0
3
Researchers from Boston University School of Medicine (BUSM) found that among all hospitalizations that were due to firearm injury, patients who underwent surgical repair of their major blood vessels had the highest injury ...
Apr 25, 2019
0
0
Overweight children may be more likely than normal-weight children to develop life-threatening blood clots as adults, a new Danish study suggests. The good news is, getting to a healthy weight by age 13 eliminated the extra ...
Mar 15, 2019
0
0
The first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk published today in the New England Journal of Medicine. The study found ...
Feb 20, 2019
0
1
Hormone replacement therapy (HRT) tablets are associated with a higher risk of rare but serious blood clots (known as venous thromboembolism or VTE), finds a large study in The BMJ today.
Jan 10, 2019
0
1
Cleveland Clinic medical oncologist and researcher, Alok Khorana, M.D., is the primary investigator on a study that concluded rivaroxaban for venous thromboembolism (VTE), a blood clot in the venous system, significantly ...
Dec 4, 2018
0
0
(HealthDay)—A patient-centered education bundle intervention can reduce nonadministration of venous thromboembolism (VTE) prophylaxis, according to a study published online Nov. 16 in JAMA Network Open.
Nov 20, 2018
0
0
Use of sodium glucose cotransporter 2 (SGLT2) inhibitors to treat type 2 diabetes is associated with an increased risk of lower limb amputation and diabetic ketoacidosis (a serious diabetes complication) compared with another ...
Nov 14, 2018
0
6
(HealthDay)—The risk of recurrence after incident venous thromboembolism is high, particularly among patients with cancer-related venous thromboembolism, according to a study published in the September issue of The American ...
Oct 1, 2018
0
0